As of March 2024 Vanda Pharmaceuticals has a market cap of $0.23 Billion. This makes Vanda Pharmaceuticals the world's 6800th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.23 B | -2.6% |
2023 | $0.24 B | -41.95% |
2022 | $0.41 B | -52.16% |
2021 | $0.87 B | 21.25% |
2020 | $0.72 B | -17.96% |
2019 | $0.87 B | -35.92% |
2018 | $1.37 B | 100.8% |
2017 | $0.68 B | -2.58% |
2016 | $0.70 B | 75.85% |
2015 | $0.39 B | -32.9% |
2014 | $0.59 B | 43.59% |
2013 | $0.41 B | 295.94% |
2012 | $0.10 B | -21.92% |
2011 | $0.13 B | -49.55% |
2010 | $0.26 B | -14.47% |
2009 | $0.31 B | 2227.25% |
2008 | $13.32 M | -92.73% |
2007 | $0.18 B | -66.38% |
2006 | $0.54 B |
On Mar 28th, 2024 the market cap of Vanda Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.20 B | 161,099.46% | ๐บ๐ธ USA |
Novartis NVS | $197.71 B | 83,509.50% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.13 B | 66,347.92% | ๐บ๐ธ USA |
Eli Lilly LLY | $739.65 B | 312,679.38% | ๐บ๐ธ USA |
Merck MRK | $334.18 B | 141,215.56% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $109.66 B | 46,273.38% | ๐บ๐ธ USA |
Titan Pharmaceuticals
TTNP | $5.78 M | -97.56% | ๐บ๐ธ USA |